Stephen P. Colegate

Stephen P. Colegate

Auto-generated profile, based on publicly available information

Stephen P. Colegate

Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, United States

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
SCStephen P. Colegate
Stephen P. Colegate
APAnushka Palipana
Anushka Palipana
EGEmrah Gecili
Emrah Gecili
RSRhonda D. Szczesniak
Rhonda D. Szczesniak
CBCole Brokamp
Cole Brokamp
Introduction: Patients with cystic fibrosis (CF) experience frequent episodes of acute decline in lung function called pulmonary exacerbations (PEx). An existing clinical and place-based precision medicine algorithm that accurately predicts PEx could include racial and ethnic biases in clinical and geospatial training data, leading to unintentional exacerbation of health inequities. Methods: We estimated receiver operating characteristic curves based on predictions from a nonstationary Gaussian stochastic process model for PEx within 3, 6, and 12 months among 26,392 individuals aged 6 years and above (2003–2017) from the US CF Foundation Patient Registry. We screened predictors to identify reasons for discriminatory model performance. Results: The precision medicine algorithm performed worse predicting a PEx among Black patients when compared with White patients or to patients of another race for all three prediction horizons. There was little to no difference in prediction accuracies among Hispanic and non-Hispanic patients for the same prediction horizons. Differences in F508del, smoking households, secondhand smoke exposure, primary and secondary road densities, distance and drive time to the CF center, and average number of clinical evaluations were key factors associated with race. Conclusions: Racial differences in prediction accuracies from our PEx precision medicine algorithm exist. Misclassification of future PEx was attributable to several underlying factors that correspond to race: CF mutation, location where the patient lives, and clinical awareness. Associations of our proxies with race for CF-related health outcomes can lead to systemic racism in data collection and in prediction accuracies from precision medicine algorithms constructed from it.

24 January 2026 in Atmospheric Environment: X
Verified
Journal Article
Open access
SCStephen P. Colegate
Stephen P. Colegate
EMErika Rasnick Manning
Erika Rasnick Manning
AVAndrew Vancil
Andrew Vancil
ZWZiyun Wang
Ziyun Wang
MRMarepalli Rao
Marepalli Rao
CBCole Brokamp
Cole Brokamp
In cystic fibrosis (CF) lung disease, increased exposure to PM2.5 (particulate matter <2.5 μm in diameter) has been linked to more frequent pulmonary exacerbations, yet the timing of exposure that presents the greatest exacerbation risk remains uncertain. Our study investigated whether short-term increases in ambient fine particulate matter (PM2.5) contribute to exacerbation risk in individuals with CF. We analyzed data from 108 participants across 17 U.S. clinical sites enrolled in the Early Intervention in Cystic Fibrosis Exacerbation study (October 2011–July 2015), who recorded forced expiratory volume in 1 s (FEV1) measurements at least twice weekly. Exacerbation cases were identified via the FEV1 indicated exacerbation signal (FIES), defined as a ≥10 % predicted decline in FEV1. Daily 24-h average PM2.5 concentrations were estimated at the residential ZIP code using a high-resolution spatiotemporal exposure model. A time-stratified case-crossover design modeled exacerbation onset and PM2.5 exposure, controlled for temperature, relative humidity, and holiday impacts. We analyzed 6936 FEV1 observations yielding 1432 exacerbation cases, averaging 7.7 cases per person-year, matched to 4794 control dates in the same year, month, and day of the week. Increased exacerbation risk occurred one (OR: 1.18; 95 % CI: 1.02–1.36), two (OR: 1.20; 95 % CI: 1.04–1.40), and three (OR: 1.23; 95 % CI: 1.05–1.43) days after PM2.5 exposure, but not on the day of onset (OR: 1.07; 95 % CI: 0.92–1.25). Integrating home-monitored lung function with hyperlocal exposure estimates provides improved temporal resolution for detecting acute environmental triggers and may inform early intervention strategies in CF care.

30 July 2025 in Journal of Clinical and Translational Science
Verified
Journal Article
Open access
PDF file
SCStephen P. Colegate
Stephen P. Colegate
MSMichael Seid
Michael Seid
DHDavid Hartley
David Hartley
AFAaron Flicker
Aaron Flicker
JBJoseph Bruce
Joseph Bruce
CBCole Brokamp
Cole Brokamp
Introduction: Asthma exacerbations are frequent causes of pediatric hospital admissions. We sought to develop a time series algorithm to forecast next-day daily asthma hospitalizations. Methods: Daily hospitalizations for asthma were collected at Cincinnati Children’s from January 1, 2016, to December 31, 2023. We evaluated Autoregressive Integrated Moving Average (ARIMA), Exponential Smoothing (ETS), Prophet, and Ensemble models to forecast next-day asthma hospitalizations validated on 2023 data, considering varying historical training data lengths. Forecasts were calibrated to identify days exceeding a 5% high-risk threshold of historical totals and considered multiple validation years and years before and during the COVID-19 pandemic. Results: A total of 5,593 hospital admissions were recorded for asthma. Over 2,922 days, 166 days met the 5% high-risk threshold equating to 6 or more admissions. The Ensemble (Median Absolute Percentage Error (MAPE): 46.7%; Positive Predictive Value (PPV): 0.278; Negative Predictive Value (NPV): 0.942; Area Under the ROC Curve (AUC): 0.740; Sensitivity: 0.800; Specificity: 0.656) model achieved higher accuracy of high-risk days than ARIMA (MAPE: 46.5%; PPV: 0.278; NPV: 0.942; AUC: 0.709; Sensitivity: 0.760; Specificity: 0.571), ETS (MAPE: 47.2%; PPV: 0.222; NPV: 0.939; AUC: 0.711; Sensitivity: 0.800; Specificity: 0.668), and Prophet (MAPE: 48.9%; PPV: 0.444; NPV: 0.951; AUC: 0.732; Sensitivity: 0.680; Specificity: 0.741) models. Conclusions: Our Ensemble model of mean predictions from ARIMA, ETS, and Prophet models was the most accurate in forecasting future asthma hospitalizations. Integrating forecasting techniques with clinical operations could enable proactive prevention through enhanced population care management.

6 September 2024 in Annals of Epidemiology
Verified
Journal Article
Closed access
SCS.P. Colegate
S.P. Colegate
MSM. Seid
M. Seid
DHDavid M Hartley
David M Hartley
JBJ. Bruce
J. Bruce
ABAndrew Beck
Andrew Beck
CBC. Brokamp
C. Brokamp